TG Therapeutics, Inc. (TGTX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-03
(Q2 2026)
— full calendar
Earnings Reports
-
TG Therapeutics (TGTX) Q1 2026: BrionV Rx Base Climbs Past 25,000, Doubling Addressable Market with SubQ Path
May 06, 2026
-
TG Therapeutics (TGTX) Q4 2025: Brionvi Franchise Grows 92% as Subcutaneous Launch Nears
February 26, 2026
-
TG Therapeutics (TGTX) Q3 2025: Brionvi Net Sales Jump 93% as SubQ Pipeline Targets $10B MS Market
November 03, 2025
-
TG Therapeutics (TGTX) Q2 2025: BrionV Share Hits 33%, Sub-Q Launch Targets $8B MS Market Expansion
August 04, 2025
-
TG Therapeutics (TGTX) Q1 2025: Briomvy Revenue Jumps 137% as Repeat Prescriptions Surpass New Starts
July 07, 2025